Camprosys 333mg Tablet is a medicine that is used to stop craving in people who have completely stopped drinking alcohol. However, this medicine does not treat alcohol withdrawal symptoms or prevent the harmful effects of alcohol abuse.

Camprosys 333mg Tablet is used in the treatment of people with drinking problems. People who drink while taking Camprosys 333mg Tablet, the patient experiences unpleasant physical features

Uses of Camprosys Tablet

Alcohol addiction

Benefits of Camprosys Tablet

In Alcohol addiction

Camprosys 333mg Tablet is a medicine used, along with social support and counseling, to help people recover from alcohol addiction and to avoid having the urge to drink alcohol again. Camprosys 333mg Tablet starts working from the very first dose and is a very safe and effective way of treating alcohol addiction.

Side effects of Camprosys Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Camprosys

Diarrhea
Abdominal pain
Nausea
Vomiting
Decreased libido
Itching
Flatulence
Impotence

How to use Camprosys Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Camprosys 333mg Tablet is to be taken with food.

Safety advice

Alcohol

CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Camprosys 333mg Tablet. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Camprosys 333mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

SAFE IF PRESCRIBED

Camprosys 333mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.

Driving

SAFE

Camprosys 333mg Tablet does not usually affect your ability to drive.

Kidney

CAUTION

Camprosys 333mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Camprosys 333mg Tablet may be needed. Please consult your doctor.
Use of Camprosys 333mg Tablet is not recommended in patients with severe kidney disease.

Liver

CAUTION

Camprosys 333mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Camprosys 333mg Tablet may be needed. Please consult your doctor.
Limited information is available on the use of Camprosys 333mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Camprosys 333mg Tablet

₹10.8/Tablet

Acamprol Tablet

Sun Pharmaceutical Industries Ltd

₹15.2/tablet

41% costlier

Acamptas 333 Tablet

Intas Pharmaceuticals Ltd

₹14.75/tablet

37% costlier

Acmacal 333mg Tablet

Psycormedies

₹9.82/tablet

9% cheaper

Fide 333mg Tablet

Psycogen Captab

₹14.5/tablet

34% costlier

Alcosate 333mg Tablet

Vega Pharma

₹21.5/tablet

99% costlier

View all substitutes

Quick tips

Camprosys 333mg Tablet reduces craving for alcohol in people who have stopped drinking.
Take it in combination with a counselling programme to help you maintain abstinence from alcohol.
It is only effective after you have completely stopped drinking alcohol.
This medicine does not relieve alcohol withdrawal symptoms and does not prevent the harmful effects of continued alcohol abuse.
Talk to your doctor if you notice sudden mood changes or develop suicidal thoughts.
It will take time, support, willpower and determination to readjust to not drinking and learn to live without alcohol.

Fact Box

Chemical Class

Organosulfonic Acid

Habit Forming

Therapeutic Class

NEURO CNS

Action Class

Alcohol deaddiction

Patient concerns

I have a problem with alcohol addiction

Dr. Aanchal Maheshwari

Ayurveda

Take gaharwar deaddiction capsule 1 capsule dailyDo ,yoga and meditation

Is kripa rehabilitation center Bangalore good for de-addiction of alcohol?

Dr. Jyoti Kapoor Madan

Psychiatry

I am not sure!

FAQs

Is Camprosys 333mg Tablet addictive/ is Camprosys 333mg Tablet a narcotic?

Camprosys 333mg Tablet is not addictive when given at prescribed dose and duration as advised by your doctor. Camprosys 333mg Tablet is a calcium acetylhomotaurinate and not a narcotic

Is Camprosys 333mg Tablet effective?

Camprosys 333mg Tablet is effective if used at prescribed dose and duration as advised by your doctor

What is acamprosate/What is acamprosate calcium used for?

Acamprosate or acamprosate calcium along with counselling is used as a therapy to maintain the practice of avoiding alcohol drinking again in people who are alcohol dependent

Does Camprosys 333mg Tablet get you high/ make you drowsy/ cause weight gain?

These side effects are rare or uncommon with Camprosys 333mg Tablet treatment. Consult your doctor immediately if you experience one or more such symptoms and stop taking Camprosys 333mg Tablet immediately.

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Stahl SM, editor. Acamprosate. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 1-3.
Schuckit MA. Ethanol and Methanol. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 643.
Masters SB. The Alcohols. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 395.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 5-6.
Acamprosate. Feltham, Middlesex: Merck; 1995 [revised Mar. 2015]. [Accessed 18 Mar. 2019] (online) Available from:
Drugs.com. Acamprosate. [Accessed 19 Mar. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:

Marketer details

Name: Neosys Medicare

Address: Plot No 315, Industrial Area Phase-2, Panchkula Haryana)-134109

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.